|
![]() |
|||
|
||||
OverviewNausea and vomiting are two of the most common side-effects of anti-cancer treatment, and the discovery and clinical application of 5-hydroxytryptamine3 receptor antagonists has transformed the management of these side effects, resulting in a much improved quality of life for cancer patients. This text presents a detailed overview of the management of cancer-treatment induced emesis in a number of different treatment settings, and focuses on the mechanisms and use of 5-HT3 receptor antagonists. Contributions are also included from the points of view of the nurse and the patient. Full Product DetailsAuthor: Mario A. DicatoPublisher: Taylor & Francis Ltd Imprint: Taylor & Francis Ltd Dimensions: Width: 18.90cm , Height: 2.30cm , Length: 24.60cm Weight: 0.861kg ISBN: 9781853172670ISBN 10: 1853172677 Pages: 248 Publication Date: 01 September 1997 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsNausea and vomiting are two of the most common side-effects of anti-cancer treatment, and the discovery and clinical application of 5-hydroxytryptamine3 receptor antagonists has transformed the management of these side effects, resulting in a much improved quality of life for cancer patients. This text presents a detailed overview of the management of cancer-treatment induced emesis in a number of different treatment settings, and focuses on the mechanisms and use of 5-HT3 receptor antagonists. Contributions are also included from the points of view of the nurse and the patient.ReviewsAuthor InformationMario A. Dicato M.D. Department of Haematology-Oncology, Centre Hospitalier de Luxembourg. Tab Content 6Author Website:Countries AvailableAll regions |